...
首页> 外文期刊>Allergy & Rhinology >Investigation of Normative Value of Commercialized Taiwan Smell Identification Test
【24h】

Investigation of Normative Value of Commercialized Taiwan Smell Identification Test

机译:商业化台湾嗅觉鉴定试验的规范性价值调查

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background The Taiwan Smell Identification Test (TWSIT) was developed and successfully administered in Taiwanese population since 2015. However, for sanitation reason, the original liquid-jar form of this test is not appropriate. The commercialized TWSIT was then re-designed as “scratch-and-sniff” version: the TIBSIT (Top International Biotech, Taipei, Taiwan). This project aims to investigate the normative value of TIBSIT in different age groups and genders. Methods Volunteers aged 20 to 80 with no subjective smell loss were recruited in a rhinology clinic. The participants were given full instructions on using the TIBSIT. Results Two hundred and nine healthy subjects (female: male =107: 102) were enrolled into this study. The median TIBSIT score in female and male subjects is 47 and 46, respectively. Subjects were further divided into three age groups: (A) 20~34?years (n?=?77), (B) 35~54?years (n?=?77), and (C) 55~80?years (n?=?55). The TIBSIT scores at the tenth percentile value at each age group of male patients are 43, 42 and 37; while the scores at the tenth percentile value at each age group of female patients are 42, 42 and 41. TIBSIT score was significantly and inversely correlated with age (Spearman rho =???0.20, p?=?0.004.). Conclusion We established the normative values of the new TIBSIT in different age groups in Taiwan. Future nation-wide screening is needed for more sophisticated norms establishment.
机译:背景技术自2015年以来,在台湾人口中开发并成功地管理台湾闻名鉴定试验(TWSIT)。然而,对于卫生原因,该测试的原始液体罐形式不合适。然后将商业化的TWSIT重新设计为“刮擦”版本:TIBSIT(Top International Biotech,台北,台湾)。该项目旨在调查不同年龄群体和家长胫骨的规范性价值。方法在申诉学诊所招募了20至80岁的志愿者,没有主观嗅觉损失。参与者有关使用TIBSIT的完整说明。结果二百九个健康受试者(女性:男性= 107:102)纳入本研究。女性和男性受试者中位数分别分别为47和46。受试者进一步分为三个年龄组:(a)20〜34?年(n?=?77),(b)35〜54?年(n?=?77),和(c)55〜80?年(n?=?55)。在每个年龄段的男性患者组的第十个百分位数的TIBSIT分数为43,42和37;虽然每个女性患者的每个年龄组的第十百分位数的分数为42,42和41. TIBSIT得分显着且与年龄相反(SPEARMAN RHO = ??? 0.20,P?0.004。)。结论我们在台湾的不同年龄群体中建立了新的TIBSIT的规范价值。对于更复杂的规范建立,需要未来的全国范围的筛选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号